Veristat’s partnership with AOBiome highlights the critical role of collaboration between CROs and biotech firms in navigating the complexities of clinical trials. This discussion at the Clinical Outsourcing Group conference underscores our commitment to advancing innovative solutions for inflammatory conditions.
SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced today that it will participate in the Clinical Outsourcing Group – Bay Area 2025 conference, taking place October 21-22, 2025 at the Hyatt Regency San Francisco Airport, Burlingame, CA. Veristat is speaking with AOBiome Therapeutics, a clinical-stage biotech company focusing on inflammatory conditions, on October 21 at 4:45 p.m. PT and will add
Source: Original Press Release
